REFERENCES
-
1
Scott-Jupp R, Lama M, Tanner M S.
Prevalence of liver disease in cystic fibrosis.
Arch Dis Child.
1991;
66
698-701
-
2
Lindblad A, Glaumann H, Strandvik B.
Natural history of liver disease in cystic fibrosis.
Hepatology.
1999;
30
1151-1158
-
3
Farber S.
Pancreatic function and disease in early life. V: Pathologic changes associated with pancreatic insufficiency in early life.
Arch Pathol.
1944;
37
238-245
-
4 Bodian M. Fibrocystic Disease of the Pancreas. New York; Grune & Stratton 1953: 104-119
-
5
Colombo C, Battezzati P M, Strazzabosco M, Podda M.
Liver and biliary problems in cystic fibrosis.
Semin Liver Dis.
1998;
18
227-235
-
6
Strandvik B, Hjelte L, Gabrielsson N, Glaumann H.
Sclerosing cholangitis in cystic fibrosis.
Scand J Gastroenterol .
1988;
143(suppl)
121-124
-
7
Nagel R A, Westaby D, Javaid A et al..
Liver disease and bile duct abnormalities in adults with cystic fibrosis.
Lancet.
1989;
2
1422-1425
-
8
Dodd III G D, Niedzwiecki G A, Campbell W L, Baron R L.
Bile duct calculi in patients with primary sclerosing cholangitis.
Radiology.
1997;
203
443-447
-
9
Girodon E, Sternberg D, Chazouilleres O et al..
Cystic fibrosis transmembrane conductance regulator (CFTR) gene defects in patients with primary sclerosing cholangitis.
J Hepatol.
2002;
37
192-197
-
10
Colombo C, Battezzati P M.
Liver involvement in cystic fibrosis: primary organ damage or innocent bystander?.
J Hepatol.
2004;
41
1041-1044
-
11
O'Brien S, Keogan M, Casey M et al..
Biliary complications of cystic fibrosis.
Gut.
1992;
33
387-391
-
12
Feranchak A P, Sokol R J.
Cholangiocyte biology and cystic fibrosis liver disease.
Semin Liver Dis.
2001;
21
471-488
-
13
Sheth S, Shea J C, Bishop M D et al..
Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis.
Hum Genet.
2003;
113
286-292
Benjamin L ShneiderM.D.
Mount Sinai School of Medicine, Box 1656
One Gustave L. Levy Place, New York, NY 10029
Email: Benjamin.Shneider@mssm.edu
